Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

ORION-9

Projekt: Typer af projekter

Vis graf over relationer
A placebo-controlled, double-blind, randomized trial to evaluate the effect of 300 mg of inclisiran sodium given as subcutaneous injections in subjects with heterozygous familial hypercholesterolemia (HEFH) and elevated low-density lipoprotein cholesterol (LDL-C)
StatusIgangværende
Periode10/01/201831/12/2019

ID: 52405390